glyburide has been researched along with Leishmaniasis, Cutaneous in 5 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho, AM | 1 |
| Novais, FO | 1 |
| Paixão, CS | 1 |
| de Oliveira, CI | 1 |
| Machado, PRL | 1 |
| Carvalho, LP | 1 |
| Scott, P | 1 |
| Carvalho, EM | 1 |
| Silva, N | 1 |
| Camacho, N | 1 |
| Figarella, K | 2 |
| Ponte-Sucre, A | 3 |
| Serrano-Martín, X | 1 |
| Payares, G | 1 |
| Mendoza-León, A | 3 |
| García, N | 1 |
| Moll, H | 1 |
5 other studies available for glyburide and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Glyburide, a NLRP3 Inhibitor, Decreases Inflammatory Response and Is a Candidate to Reduce Pathology in Leishmania braziliensis Infection.
Topics: Biopsy; Brazil; Cells, Cultured; Cytokines; Endemic Diseases; Glyburide; Humans; Hypoglycemic Agents | 2020 |
Cell differentiation and infectivity of Leishmania mexicana are inhibited in a strain resistant to an ABC-transporter blocker.
Topics: Animals; ATP-Binding Cassette Transporters; Blotting, Western; Cell Differentiation; Drug Resistance | 2004 |
Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis.
Topics: Adenosine Triphosphate; Animals; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Resist | 2006 |
Changes in the infectivity, pyruvate kinase activity, acid phosphatase activity and P-glycoprotein expression in glibenclamide-resistant Leishmania mexicana.
Topics: Acid Phosphatase; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cultu | 2000 |
Experimental leishmaniasis: synergistic effect of ion channel blockers and interferon-gamma on the clearance of Leishmania major by macrophages.
Topics: Animals; Cells, Cultured; Drug Synergism; Glyburide; Interferon-gamma; Ion Channels; Leishmania majo | 2001 |